Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Bayer named strategy chief Werner Baumann to replace Marijn Dekkers as CEO, prompting some industry watchers to speculate that there’s more deal-making ahead for the German firm’s non-pharma markets.
Baumann, who’s slated to succeed Dekkers May 1, joined Bayer in 1988 and made a name for himself with the successful integration of rival drugmaker Schering in 2006 – at the time Bayer’s biggest-ever takeover – and was a driving force behind the acquisition of Merck & Co’s consumer health unit 8 years later. Read more
Nico Corp. said it raised $15 million of a hoped-for $18 million funding round, led by prior backers River Cities Capital Funds and the Rose-Hulman Institute of Technology, for its BrainPath neurosurgery device.
Indianapolis-based Nico said in a regulatory filing that 41 investors participated in the round, which nearly doubled its previous fundraising efforts. Read more
A federal jury in California slapped NUVA with a $41.8 million judgment after finding that the spinal implant maker poached sales reps from 1 of its distributors.
Madsen Medical, a Nevada-based distributor, sued San Diego-based NuVasive in September 2013, after being fired in 2012. Owner Kris Madsen alleged that NuVasive breached its contract when it lured 6 Madsen Medical reps to sell directly to their former Madsen clients, according to court documents. Read more